Glasgow coma scale

Glasgow Coma Scale (GCS)

The Glasgow Coma Scale (GCS) is one of the most widely used neurological assessment tools in clinical practice. Developed in 1974 by Professors Graham Teasdale and Bryan Jennett at the University of Glasgow, the scale provides a standardised method of assessing a patient’s level of consciousness following head injury or other conditions affecting brain function.

Today, the Glasgow Coma Scale is used worldwide in emergency medicine, trauma care, intensive care, neurosurgery, ambulance services, and acute medical settings. It enables healthcare professionals to rapidly assess neurological status, monitor changes over time, and communicate findings using a universally recognised scoring system.

Components of the Glasgow Coma Scale

The GCS assesses three aspects of neurological function:

Eye Opening (E)

Eye opening evaluates the patient’s ability to open their eyes either spontaneously or in response to stimulation.

Scores range from:

  • 4 – Opens eyes spontaneously
  • 3 – Opens eyes to speech
  • 2 – Opens eyes to pain
  • 1 – No eye opening

Verbal Response (V)

The verbal response assesses orientation, speech, and the patient’s ability to communicate.

Scores range from:

  • 5 – Oriented
  • 4 – Confused conversation
  • 3 – Inappropriate words
  • 2 – Incomprehensible sounds
  • 1 – No verbal response

For patients who are intubated or otherwise unable to speak, this component should be documented appropriately rather than estimated.

Motor Response (M)

Motor response is generally regarded as the most clinically significant component of the GCS, evaluating the patient’s ability to obey commands or respond to painful stimuli.

Scores range from:

  • 6 – Obeys commands
  • 5 – Localises pain
  • 4 – Withdraws from pain
  • 3 – Abnormal flexion (decorticate posture)
  • 2 – Extension (decerebrate posture)
  • 1 – No motor response

Calculating the Total Score

The three component scores are added together to produce a total Glasgow Coma Scale score ranging from 3 to 15.

General interpretation is:

  • 13–15: Mild impairment of consciousness
  • 9–12: Moderate impairment
  • 3–8: Severe impairment or coma

Patients with a GCS of 8 or less often require urgent airway assessment and critical care management, although treatment decisions should always be based on the overall clinical picture.

Clinical Applications

The Glasgow Coma Scale is routinely used in the assessment of:

  • Traumatic brain injury
  • Stroke
  • Intracranial haemorrhage
  • Seizures
  • Drug or alcohol intoxication
  • Metabolic encephalopathy
  • Meningitis and encephalitis
  • Cardiac arrest
  • Critically ill patients

Repeated GCS assessments allow clinicians to detect neurological deterioration or improvement over time, making serial observations particularly valuable.

Limitations

Although the Glasgow Coma Scale is an essential neurological assessment tool, it has recognised limitations. Factors such as sedation, neuromuscular blockade, intubation, language barriers, hearing impairment, facial injuries, intoxication, or pre-existing neurological disease may affect assessment accuracy.

For this reason, GCS should always be interpreted alongside a comprehensive neurological examination, vital signs, imaging findings, and the patient’s overall clinical condition.

Glasgow Coma Scale and Clinical Calculators

The Glasgow Coma Scale forms part of several validated clinical calculators and scoring systems, including the SOFA Score, APACHE II, Revised Trauma Score, and other emergency and critical care assessment tools. Accurate GCS assessment therefore contributes to illness severity scoring, prognosis, and treatment planning.

At MediCalc, the Glasgow Coma Scale calculator is based on the original validated scoring system and provides healthcare professionals with a rapid and reliable method of calculating the total GCS score. It is intended to support neurological assessment and should always be interpreted alongside current clinical guidelines and professional judgement.

The Glasgow Coma Scale remains one of the most important bedside assessment tools in modern medicine, providing a consistent and internationally recognised method of evaluating consciousness, monitoring neurological change, and supporting evidence-based patient care.